Safety Study of rhASM Enzyme Replacement Therapy in Adults With Acid Sphingomyelinase Deficiency (Niemann-Pick Disease)
Clinical trial NCT00410566 · TERMINATED
Trial details
- NCT number
- NCT00410566
- Sponsor
- Genzyme, a Sanofi Company
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2006-12-01
- Primary completion
- 2009-03-01
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.